STOCK-BASED COMPENSATION (Details Narrative) - USD ($) |
3 Months Ended | |||
|---|---|---|---|---|
Oct. 21, 2015 |
Mar. 31, 2018 |
Mar. 31, 2017 |
Jun. 29, 2016 |
|
| Independent Directors ( Dr. Mark Baker, Mr. Mark Pastreich, Mr. Arthur Radin and Mr. Cyril Narishkin) [Member] | ||||
| Description of payment terms |
Paid quarterly half in cash and half in common stock |
|||
| Annually compensation paid per director | $ 25,000 | |||
| 2015 Stock Option Plan [Member] | ||||
| Number of shares authorized | 4,000,000 | |||
| Number of common shares awarded | 500,000 | |||
| Weighted average grant date fair value of stock options | $ 0.00 | $ 0.25 | ||
| Allocated stock-based compensation expense | $ 12,183 | $ 16,580 | ||
| Weighted-average grant-date fair value options granted | 0 | 122,656 | ||
| Total unrecognized compensation cost | $ 65,437 | |||
| Weighted-average period (in years) | 17 months | |||
| Total fair value of shares vested | $ 156,425 | $ 98,432 | ||
| 2015 Stock Option Plan [Member] | Key Employees [Member] | ||||
| Number of common shares awarded | 1,038,000 | |||
| X | ||||||||||
- Definition it refers the amount of share based payment award grants in period. No definition available.
|
| X | ||||||||||
- Definition Represents the expense recognized during the period arising from equity-based compensation arrangements (for example, shares of stock, unit, stock options or other equity instruments) with employees, directors and certain consultants qualifying for treatment as employees. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition The compensation expense recognized during the period pertaining to the deferred compensation arrangement. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Unrecognized cost of unvested share-based compensation awards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition A description of the related party transaction, including transactions to which no amounts or nominal amounts were ascribed and such other information deemed necessary to an understanding of the effects of the transactions on the financial statements. Examples of common related party transactions are, sales, purchases and transfers of realty and personal property, services received or furnished, loans and leases to and from top management and affiliates. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The maximum number of shares (or other type of equity) originally approved (usually by shareholders and board of directors), net of any subsequent amendments and adjustments, for awards under the equity-based compensation plan. As stock or unit options and equity instruments other than options are awarded to participants, the shares or units remain authorized and become reserved for issuance under outstanding awards (not necessarily vested). Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. No definition available.
|
| X | ||||||||||
- Definition The weighted average grant-date fair value of options granted during the reporting period as calculated by applying the disclosed option pricing methodology. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Definition Fair value of options vested. Excludes equity instruments other than options, for example, but not limited to, share units, stock appreciation rights, restricted stock. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|
| X | ||||||||||
- Details
|